Anavex Life Sciences (AVXL) Stock: Gaining On Clinical Data

Anavex Life Sciences Corp (NASDAQ: AVXL) presented some very positive news this morning, exciting investors and sending the stock on a run for the top. The data was presented in a late-breaking presentation at a large medical conference. Today, we’ll talk about: The presentation; what we’re seeing from AVXL as a result; and what we’ll … Read more

Anavex Life Sciences Corp (AVXL) Stock: Headed Up On Regulatory News

Anavex Life Sciences Corp (NASDAQ: AVXL) is having a relatively strong start to the trading session in the pre-market hours, finding its way up on news that was released just minutes ago. The news surrounds the Spanish regulatory approval of a clinical trial that proved to be a point of excitement for investors. Today, we’ll … Read more

Anavex Life Sciences (AVXL) Announces Management Team Additions

Anavex Life Sciences (NASDAQ: AVXL) is likely to have an incredibly strong day in the market today, and for good reason. In a press release issued early this morning, the company announced that it has strengthened its management team, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about … Read more

Anavex Life Sciences (AVXL): Rips Higher At Open – Can It Hold?

Anavex Life Sciences Corp common stock (NASDAQ: AVXL) Anavex Life Sciences ripped higher by over 19% at the market open on an update that its phase 2a study to treat mild-to-moderate Alzheimer’s disease using ANAVEX 2-73 has provided positive data in targeting cellular homeostasis. Is The Gain Warranted? AVXL reported that after 41 weeks, Alzheimer … Read more